Douglas E. Merkel
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies
- Oncology top 2%
- Cancer survivorship and care
- HER2/EGFR in Cancer Research
- Cancer Treatment and Pharmacology
Papers in
- Oncology 23
- Cancer Treatment and Pharmacology 5
- HER2/EGFR in Cancer Research 5
- Drug Transport and Resistance Mechanisms 3
-
- Breast Cancer Treatment Studies 6
- Cancer Genomics and Diagnostics 5
- Co-authors
- David CellaAmy H. PetermanDavid T. EtonJin‐Shei LaiWilliam McGuireL. G. DresslerDavid W. HedleyTimothy E. Kute
- Journals
- Journal of Clinical Oncology (4 papers)Cancer (2 papers)Cancer treatment and research (2 papers)SpringerPlus (1 paper)Journal of Cancer Survivorship (1 paper)
- Partner nations
- United StatesNetherlandsSweden
In The Last Decade
Douglas E. Merkel
26 papers receiving 2.1k citations
Hit Papers
Peers
Comparison fields: 5 of 113
- Cancer Research 675
- Oncology 1.2k
- Pathology and Forensic Medicine 417
- Pediatrics, Perinatology and Child Health 276
- Pulmonary and Respiratory Medicine 430
Countries citing papers authored by Douglas E. Merkel
This map shows the geographic impact of Douglas E. Merkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas E. Merkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas E. Merkel more than expected).
Fields of papers citing papers by Douglas E. Merkel
This network shows the impact of papers produced by Douglas E. Merkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas E. Merkel. The network helps show where Douglas E. Merkel may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Douglas E. Merkel, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 30 | |
| 2 | 2011 | 27 | |
| 3 | 2004 | 83 | |
| 4 | 2003 | 76 | |
| 5 | 2002 | 5 | |
| 6 | Combining Anchor and Distribution-Based Methods to Derive Minimal Clinically Important Differences on the Functional Assessment of Cancer Therapy (FACT) Anemia and Fatigue Scales Hit paper breakdown → | 2002 | 652 |
| 7 | 1997 | 121 | |
| 8 | 1996 | 29 | |
| 9 | 1994 | 9 | |
| 10 | 1993 | 163 | |
| 11 | 1993 | 54 | |
| 12 | 1993 | 30 | |
| 13 | 1992 | 1 | |
| 14 | 1990 | 249 | |
| 15 | 1989 | 3 | |
| 16 | 1989 | 74 | |
| 17 | 1989 | 62 | |
| 18 | 1989 | 5 | |
| 19 | 1989 | 2 | |
| 20 | 1987 | 226 |
About Douglas E. Merkel
Douglas E. Merkel is a scholar working on Oncology, Cancer Research, Pathology and Forensic Medicine, Pharmacology and Radiology, Nuclear Medicine and Imaging, having authored 26 papers that have together received 2.2k indexed citations. Recurring topics across this work include Breast Cancer Treatment Studies (6 papers), Cancer Treatment and Pharmacology (5 papers), HER2/EGFR in Cancer Research (5 papers), Cancer Genomics and Diagnostics (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Glycosylation and Glycoproteins Research (3 papers), Breast Lesions and Carcinomas (3 papers) and Drug Transport and Resistance Mechanisms (3 papers). The work is most often cited by research in Cancer Research (675 citations), Oncology (1.2k citations), Pathology and Forensic Medicine (417 citations), Pediatrics, Perinatology and Child Health (276 citations) and Pulmonary and Respiratory Medicine (430 citations). Douglas E. Merkel has collaborated with scholars based in United States, Netherlands and Sweden. Frequent co-authors include David Cella, Amy H. Peterman, David T. Eton, Jin‐Shei Lai, William McGuire, L. G. Dressler, David W. Hedley, Timothy E. Kute, Gary M. Clark and Cees J. Cornelisse. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Cancer treatment and research, SpringerPlus and Journal of Cancer Survivorship.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.